Clinical trial
Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's…
NCT00195715 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00195715 |
|---|---|
| Title | Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease |
| Official title | A Multi Center, Open Label Study of the Human Anti TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Crohn's Disease |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Biological |
| Interventions | Adalimumab |
| Enrollment | 777 |
| Start date | Sep 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Dec 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 12, 2011 |
| Countries | Australia, Belgium, Canada, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, South Africa, Spain and 3 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: